Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
23.49
+0.10 (0.43%)
May 28, 2026, 3:34 PM EDT - Market open
Ultragenyx Pharmaceutical (RARE) Revenue by Segment
History
| Date | Product | Other |
|---|---|---|
| Mar 31, 2026 | 366.81M | 302.62M |
| Dec 31, 2025 | 369.31M | 303.42M |
| Sep 30, 2025 | 339.18M | 291.43M |
| Jun 30, 2025 | 321.49M | 288.69M |
| Mar 31, 2025 | 314.47M | 276.21M |
| Dec 31, 2024 | 285.47M | 274.71M |
| Sep 30, 2024 | 265.30M | 257.40M |
| Jun 30, 2024 | 230.30M | 250.90M |
| Mar 31, 2024 | 198.70M | 243.80M |
| Dec 31, 2023 | 180.40M | 253.80M |
| Sep 30, 2023 | 157.60M | 252.60M |
| Jun 30, 2023 | 147.80M | 245.10M |
| Mar 31, 2023 | 136.40M | 237.50M |
| Dec 31, 2022 | 118.90M | 234.40M |
| Sep 30, 2022 | 110.20M | 223.00M |
| Jun 30, 2022 | 99.70M | 234.40M |
| Mar 31, 2022 | 87.20M | 244.50M |
| Dec 31, 2021 | 77.00M | 274.20M |
| Sep 30, 2021 | 69.80M | 289.70M |
| Jun 30, 2021 | 59.00M | 300.30M |
Source: Business metrics provided by TipRanks and sourced from official company press releases and documents.